Active transport of fluorescent P-glycoprotein substrates: Evaluation as markers and interaction with inhibitors

Biochemical and Biophysical Research Communications

Volumn 289, Issue 2, 2001, Pages 580-585

  Wang, Er jia ^a   Casciano, Christopher N ^a   Clement, Robert P ^a   Johnson, William W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Drug interaction; Inhibition; MDR; Mechanism; P glycoprotein

Indexed keywords

CALCEIN; CARVEDILOL; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSPORIN A; DAUNORUBICIN; DIPYRIDAMOLE; EMETINE; FELODIPINE; FLUPHENAZINE; FORSKOLIN; GLYCOPROTEIN P; KETOCONAZOLE; MEVINOLIN; NICARDIPINE; NORGALLOPAMIL; PACLITAXEL; PROGESTERONE; QUINIDINE; QUININE; RESERPINE; RHODAMINE 123; SIMVASTATIN; TAMOXIFEN; TERFENADINE; TRIFLUOPERAZINE; TROLEANDOMYCIN; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE;

ACTIVE TRANSPORT; ARTICLE; BINDING SITE; CELL VIABILITY; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN TRANSPORT;

EID: 0035976774     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6000     Document Type: Article

References (24)

1. Biochemistry of multidrug resistance mediated by the multidrug transporter
2. P-glycoprotein and multidrug resistance
3. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
4. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein
5. Inhibition of P-glycoprotein transport function by grapefruit juice psoralen
6. Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein
7. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein
8. The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein
9. Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools
10. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein
11. Two transport binding sites of P-glycoprotein are unequal yet contingent: Initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependency
12. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase - Further experimental evidence for a multisite model
13. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents
14. Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity
15. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein
16. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities
17. Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: Evidence for half-of-the-sites reactivity
18. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein
19. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor
20. Symmetry and structure in P-glycoprotein and ABC transporters: What goes around comes around
21. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein
22. Structure of MsbA from E. coli: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters
23. Determining the dimensions of the drug-binding domain of human p-glycoprotein using thiol cross-linking compounds as molecular rulers
24. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane